Alomone Labs Chlorpromazine hydrochloride reversibly inhibits nicotinic receptors heterologously expressed inXenopusoocytes. - A. Time course of the inhibitory effect of 10 MChlorpromazine hydrochloride(#C-165) on ?7 nicotinic currents elicited at -80 mV holding potential by continuous stimulation with 100 M ACh + 3 MPNU 282987(#P-110) every 50 sec (indicated by uppermost horizontal bars). B. Superimposed traces of channel activity before and during application of the indicated Chlorpromazine concentration (taken from the experiment shown in panel A).
Western blot analysis of human HL-60 (lanes 1 and 4) THP-1 (lanes 2 and 5) and MEG-O1 (lanes 3 and 6) cell lysates: - 1-3. Anti-Human CCR5 (extracellular) Antibody (#ACR-025) (1:400).4-6. Anti-Human CCR5 (extracellular) Antibody preincubated with the negative control antigen.
quantity: 5 g, 10 g, 25 g, 50 g, 100 g
price:
to the supplier
Peptide (C)DRVFDVNDKVENSLE corresponding to amino acid residues 172-186 of human Ephrin-A5 (Accession P52803). Extracellular.
quantity: 50 mg, 100 mg, 250 mg, 500 mg
price:
to the supplier
Alomone LabsVU591 hydrochlorideblocks Kir1.1 channels expressed inXenopusoocytes. - A. Kir1.1 channel currents were elicited by 150 ms voltage ramp from -120 mV to +60 mV (HP -90 mV no leak subtraction).VU591 hydrochloride(#V-126) was applied at 10 M as indicated and inhibited the Kir1.1 channel current in a reversible manner. B. Example current traces before and during application of 10 M VU591 hydrochloride from the experiment shown in A.
quantity: 1 g, 5 g, 10 g, 25 g
price:
to the supplier